All In Biotech

Drug Trial Radar · NCT02856113

Phase 3 Alogliptin Pediatric Study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Alogliptin Compared With Placebo in Pediatric Subjects With Type 2 Diabetes Mellitus

Last checked: Nov 19, 2026Latest source record: Oct 19, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 152 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

152

Actual

Start

Oct 14, 2016

Primary completion

Aug 6, 2021

Study completion Feb 14, 2022

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
Collaborators
Takeda Development Center Americas, Inc.
First posted
Aug 4, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 10 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this study is to evaluate the efficacy of alogliptin 25 milligram (mg) once daily compared to placebo when administered as monotherapy, or when added onto a background of metformin alone, insulin alone, or a combination of metformin and insulin, as measured by the glycosylated hemoglobin (HbA1c) change from Baseline at Week 26 in pediatric participants with type 2 diabetes mellitus (T2DM).

Conditions

  • Diabetes Mellitus, Type 2

Interventions

  • Alogliptin BenzoateDrug

    Alogliptin benzoate tablets.

  • PlaceboDrug

    Alogliptin placebo-matching tablets.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 26Time frame: Baseline and Week 26

Locations

67 sites in 7 countries. Site status is shown where the registry gives one.

  • Arkansas Children's Hospital Research Institute

    Little Rock, Arkansas

  • Children's Hospital Los Angeles

    Los Angeles, California

  • Sherif Khamis

    Palmdale, California

  • Lucile Packard Children's Hospital at Stanford University

    Palo Alto, California

  • Touro University California

    Vallejo, California

  • Yale New Haven Hospital

    New Haven, Connecticut

  • Children's National Health System

    Washington D.C., District of Columbia

  • University of Florida

    Gainesville, Florida

  • Nemours Childrens Specialty Care - Jacksonville

    Jacksonville, Florida

  • Baptist Diabetes Associates Research

    Miami, Florida

  • University of South Florida/USF Health

    Tampa, Florida

  • Endocrine Consultants Research

    Columbus, Georgia

  • Endocrine Consultants Research - Oak Hill Court

    Newnan, Georgia

  • Ann & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois

  • Indiana University

    Indianapolis, Indiana

  • University of Iowa

    Iowa City, Iowa

  • University of Kentucky Health Care

    Lexington, Kentucky

  • Pennington Biomedical Research Center

    Baton Rouge, Louisiana

  • Ochsner Baptist Medical Center

    New Orleans, Louisiana

  • University of Minnesota Masonic Children's Hospital - Pediatric Specialty Care Discovery Clinic

    Minneapolis, Minnesota

  • Gulfside Clinical Research

    Gulfport, Mississippi

  • Saint Louis University

    St Louis, Missouri

  • Horizon View Medical Center

    Las Vegas, Nevada

  • Saint Joseph's Regional Medical Center - Paterson

    Paterson, New Jersey

  • University of Rochester

    Rochester, New York

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

  • Greenville Health System - Patewood

    Greenville, South Carolina

  • Monument Health Clinical Research

    Rapid City, South Dakota

  • UT Le Bonheur Pediatric Specialists

    Memphis, Tennessee

  • University of Texas Southwestern Medical Center

    Dallas, Texas

  • Baylor College of Medicine Advanced Liver Therapies

    Houston, Texas

  • University of Virginia

    Charlottesville, Virginia

  • Seattle Children's Hospital

    Seattle, Washington

  • Multicare Health System Institute for Research and Innovation

    Tacoma, Washington

  • Hospital Sirio Libanes

    São Paulo, Brazil

  • Instituto de Estudos e Pesquisas Clinicas do Ceara

    Fortaleza, Ceará, Brazil

  • Hospital Universitario Joao de Barros Barreto

    Belém, Pará, Brazil

  • Instituto da Crianca com Diabetes

    Porto Alegre, Rio Grande do Sul, Brazil

  • Hadassah University Hospital Mount Scopus

    Jerusalem, Israel

  • Clalit Medical Center

    Tel Aviv, Israel

Showing 40 of 67 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.